Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implantation | 18 | 2025 | 50 | 6.460 |
Why?
|
| Cochlear Implants | 16 | 2024 | 51 | 5.780 |
Why?
|
| Speech Perception | 15 | 2025 | 49 | 5.430 |
Why?
|
| Tinnitus | 2 | 2023 | 19 | 1.010 |
Why?
|
| Neuroma, Acoustic | 5 | 2025 | 28 | 0.910 |
Why?
|
| Temporal Bone | 3 | 2021 | 36 | 0.900 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2022 | 7 | 0.820 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2022 | 141 | 0.780 |
Why?
|
| Reoperation | 1 | 2024 | 832 | 0.730 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2020 | 16 | 0.690 |
Why?
|
| Encephalocele | 1 | 2020 | 51 | 0.660 |
Why?
|
| Retrospective Studies | 25 | 2025 | 16312 | 0.650 |
Why?
|
| High Fidelity Simulation Training | 1 | 2019 | 4 | 0.640 |
Why?
|
| Paranasal Sinuses | 1 | 2019 | 19 | 0.640 |
Why?
|
| Scalp | 1 | 2019 | 57 | 0.640 |
Why?
|
| Free Tissue Flaps | 1 | 2019 | 51 | 0.630 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 84 | 0.620 |
Why?
|
| Adenoidectomy | 1 | 2019 | 74 | 0.610 |
Why?
|
| Endoscopy | 2 | 2024 | 280 | 0.600 |
Why?
|
| Tonsillectomy | 1 | 2019 | 97 | 0.580 |
Why?
|
| Treatment Outcome | 18 | 2025 | 12324 | 0.510 |
Why?
|
| Patient Readmission | 1 | 2019 | 383 | 0.510 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 380 | 0.480 |
Why?
|
| Radiosurgery | 3 | 2025 | 109 | 0.420 |
Why?
|
| Hearing | 5 | 2025 | 52 | 0.380 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 1086 | 0.380 |
Why?
|
| Adult | 18 | 2025 | 29435 | 0.370 |
Why?
|
| Deafness | 2 | 2023 | 83 | 0.360 |
Why?
|
| Osteoradionecrosis | 2 | 2021 | 13 | 0.360 |
Why?
|
| Humans | 32 | 2025 | 124592 | 0.320 |
Why?
|
| Microsurgery | 2 | 2025 | 68 | 0.280 |
Why?
|
| Ear, Inner | 2 | 2025 | 50 | 0.270 |
Why?
|
| Quality of Life | 3 | 2024 | 1915 | 0.240 |
Why?
|
| Hearing Loss | 2 | 2025 | 134 | 0.240 |
Why?
|
| Mastoidectomy | 1 | 2024 | 6 | 0.230 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2024 | 12 | 0.230 |
Why?
|
| Glomus Tympanicum | 1 | 2024 | 2 | 0.230 |
Why?
|
| Male | 15 | 2025 | 61194 | 0.220 |
Why?
|
| Presbycusis | 1 | 2023 | 1 | 0.220 |
Why?
|
| Prosthesis Failure | 1 | 2024 | 158 | 0.210 |
Why?
|
| Patient Preference | 1 | 2024 | 116 | 0.210 |
Why?
|
| Cadaver | 2 | 2023 | 129 | 0.210 |
Why?
|
| Diathermy | 1 | 2022 | 4 | 0.200 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2025 | 264 | 0.200 |
Why?
|
| Aged | 11 | 2025 | 19700 | 0.190 |
Why?
|
| Language | 1 | 2023 | 200 | 0.190 |
Why?
|
| Electrodes, Implanted | 1 | 2022 | 169 | 0.190 |
Why?
|
| Radiotherapy, Conformal | 1 | 2021 | 55 | 0.180 |
Why?
|
| Otosclerosis | 1 | 2021 | 4 | 0.180 |
Why?
|
| Female | 14 | 2025 | 66483 | 0.180 |
Why?
|
| Pentoxifylline | 1 | 2020 | 20 | 0.180 |
Why?
|
| Differential Threshold | 1 | 2020 | 11 | 0.170 |
Why?
|
| Labyrinthitis | 1 | 2020 | 10 | 0.170 |
Why?
|
| Auditory Cortex | 1 | 2020 | 29 | 0.170 |
Why?
|
| Anticoagulants | 1 | 2025 | 589 | 0.170 |
Why?
|
| Dehydration | 1 | 2019 | 39 | 0.160 |
Why?
|
| Brain Stem | 1 | 2020 | 115 | 0.160 |
Why?
|
| Gelatin | 1 | 2019 | 16 | 0.160 |
Why?
|
| Microvessels | 1 | 2019 | 56 | 0.160 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 133 | 0.160 |
Why?
|
| Virtual Reality | 1 | 2019 | 28 | 0.160 |
Why?
|
| Middle Aged | 9 | 2025 | 26712 | 0.150 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 6533 | 0.150 |
Why?
|
| Postoperative Period | 1 | 2019 | 333 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 236 | 0.150 |
Why?
|
| Models, Anatomic | 1 | 2019 | 99 | 0.150 |
Why?
|
| Random Allocation | 1 | 2019 | 436 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 1139 | 0.140 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2019 | 168 | 0.140 |
Why?
|
| Infant | 2 | 2024 | 12466 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 490 | 0.130 |
Why?
|
| Age Factors | 2 | 2021 | 2816 | 0.130 |
Why?
|
| Child, Preschool | 2 | 2024 | 14007 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2019 | 670 | 0.120 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2025 | 15 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 808 | 0.110 |
Why?
|
| Child | 3 | 2024 | 24367 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2019 | 998 | 0.100 |
Why?
|
| Machine Learning | 2 | 2023 | 250 | 0.080 |
Why?
|
| Medicare | 2 | 2022 | 424 | 0.080 |
Why?
|
| Time Factors | 1 | 2019 | 6293 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2019 | 1176 | 0.080 |
Why?
|
| Obesity | 1 | 2020 | 2262 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2019 | 8190 | 0.070 |
Why?
|
| Adolescent | 2 | 2024 | 19275 | 0.060 |
Why?
|
| Ear Neoplasms | 1 | 2025 | 12 | 0.060 |
Why?
|
| Hearing Aids | 1 | 2024 | 17 | 0.060 |
Why?
|
| Tympanoplasty | 1 | 2024 | 9 | 0.060 |
Why?
|
| Mastoid | 1 | 2024 | 24 | 0.060 |
Why?
|
| Neurilemmoma | 1 | 2025 | 44 | 0.060 |
Why?
|
| Petrous Bone | 1 | 2023 | 5 | 0.050 |
Why?
|
| Endoscopes | 1 | 2023 | 20 | 0.050 |
Why?
|
| Speech | 1 | 2024 | 61 | 0.050 |
Why?
|
| Cranial Sinuses | 1 | 2023 | 12 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2025 | 195 | 0.050 |
Why?
|
| Electrosurgery | 1 | 2022 | 16 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 5145 | 0.050 |
Why?
|
| Tocopherols | 1 | 2020 | 8 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2022 | 579 | 0.040 |
Why?
|
| Patient Selection | 1 | 2023 | 693 | 0.040 |
Why?
|
| Urban Population | 1 | 2021 | 225 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 80 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 665 | 0.030 |
Why?
|
| United States | 2 | 2022 | 10887 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1232 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2023 | 3280 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1619 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 2090 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 3693 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 6135 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 3138 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 4624 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 3443 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 3554 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9012 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 10265 | 0.020 |
Why?
|